<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-140077" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Ocular Sarcoidosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Simakurthy</surname>
            <given-names>Sriram</given-names>
          </name>
          <aff>AIIMS, NEW DELHI</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tripathy</surname>
            <given-names>Koushik</given-names>
          </name>
          <aff>ASG Eye Hospital, BT Road, Kolkata, India</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sriram Simakurthy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Koushik Tripathy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-140077.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Sarcoidosis is a chronic multisystemic granulomatous disorder characterized by the accumulation of non-caseating granulomas in the involved tissues. Patients with ocular sarcoidosis present with a myriad of clinical features such as uveitis, conjunctival nodules, eyelid thickening, orbital inflammation, and facial nerve palsy. This activity reviews the evaluation and treatment of ocular sarcoidosis and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathogenesis of ocular sarcoidosis.</p></list-item><list-item><p>Summarize the relevant history of patients with ocular sarcoidosis.</p></list-item><list-item><p>Review the evaluation process of patients with ocular sarcoidosis.</p></list-item><list-item><p>Outline the management of ocular sarcoidosis, including the role of interprofessional care of these patients.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140077&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140077">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-140077.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Sarcoidosis is a chronic multisystemic granulomatous disorder characterized by the accumulation of non-caseating granulomas in the involved tissues. Ocular sarcoidosis is an inflammatory condition that can involve any part of the eye leading to conjunctival granuloma, episcleritis/scleritis, uveitis, optic neuropathy, and/ or its adnexal tissues leading to lacrimal gland enlargement and orbital inflammation.<xref ref-type="bibr" rid="article-140077.r1">[1]</xref></p>
        <p>The clinical course shows variability. Few patients may have acute self-limited disease, while others experience chronic, progressive deterioration. Corticosteroids remain the mainstay of treatment with the newer addition of immunosuppressants and biologics in the treatment armamentarium.</p>
      </sec>
      <sec id="article-140077.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of sarcoidosis remains unknown, but evidence has pointed to various infective, non-infective, and genetic factors.</p>
        <p><bold>Infective etiology</bold>&#x000a0;&#x02013; The presence of bacterial DNA fragments in sarcoid granulomas&#x000a0;and regional granulomatous response following inoculation of sarcoid material in experimental animals suggests infective etiology.<xref ref-type="bibr" rid="article-140077.r2">[2]</xref>&#x000a0;Few cases of transmission of cases of sarcoidosis post organ transplantation suggest the presence of a transmissible agent.<xref ref-type="bibr" rid="article-140077.r3">[3]</xref>&#x000a0;One hypothesis has suggested that tuberculosis and sarcoidosis may be the 'opposite ends of the same disease spectrum.'<xref ref-type="bibr" rid="article-140077.r4">[4]</xref>&#x000a0;</p>
        <p>The&#x000a0;similarities in clinical features, epidemiology, immunological, and molecular link between the two diseases, and similar immune response may support the hypothesis.<xref ref-type="bibr" rid="article-140077.r4">[4]</xref>&#x000a0;Molecular studies have suggested the role of Mycobacterium&#x000a0;or Propionibacterium&#x000a0;in the causation of sarcoidosis.<xref ref-type="bibr" rid="article-140077.r5">[5]</xref></p>
        <p><bold>Non-infective etiology</bold>&#x000a0;&#x02013; Sarcoidosis with pulmonary manifestation is known to occur as an occupational disease.<xref ref-type="bibr" rid="article-140077.r6">[6]</xref><xref ref-type="bibr" rid="article-140077.r7">[7]</xref>&#x000a0;It is thought to occur secondary to air-borne organic and nonorganic dust exposure.<xref ref-type="bibr" rid="article-140077.r8">[8]</xref><xref ref-type="bibr" rid="article-140077.r9">[9]</xref></p>
        <p><bold>Genetic factor</bold>&#x000a0;&#x02013; Association between sarcoidosis and certain human leukocyte antigen haplotypes support the role of genetic factors. HLA-DRB1*1101 allele is associated with sarcoidosis and has a population-attributable risk of 9% in whites and 16% in blacks.<xref ref-type="bibr" rid="article-140077.r10">[10]</xref>&#x000a0;Greater prevalence of the disease in certain sibling pairs or parent-offspring pairs suggests genetic factors to be as important as environmental factors.<xref ref-type="bibr" rid="article-140077.r11">[11]</xref>&#x000a0;Siblings have a five times higher chance of developing sarcoidosis.<xref ref-type="bibr" rid="article-140077.r12">[12]</xref><xref ref-type="bibr" rid="article-140077.r13">[13]</xref></p>
      </sec>
      <sec id="article-140077.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence of sarcoidosis varies from region to region due to differences in case definition, asymptomatic nature of the disease, limited population screening, and ascertainment bias. In the United States, the age-adjusted incidence is reportedly three times higher in Blacks than Whites.<xref ref-type="bibr" rid="article-140077.r14">[14]</xref>&#x000a0;</p>
        <p>In a recent study by Baughman et al., the incidence of sarcoidosis in the United States ranged from 8.1 per 100,000 in&#x000a0;White race individuals to 17.8 in African Americans.<xref ref-type="bibr" rid="article-140077.r15">[15]</xref>&#x000a0;Northern European countries have the highest prevalence of sarcoidosis (40 in 100,000 population).<xref ref-type="bibr" rid="article-140077.r16">[16]</xref>&#x000a0;The prevalence of ocular features in cases of systemic sarcoidosis ranges from 12 to 76%.&#x000a0;Uveitis is the most frequent ocular manifestation. In patients with systemic sarcoidosis, females (56%) were more commonly noted to develop ocular symptoms than men (23%) in patients with biopsy-proven sarcoidosis.<xref ref-type="bibr" rid="article-140077.r17">[17]</xref>&#x000a0;</p>
        <p>The usual age at presentation of sarcoidosis is 20&#x000a0;to 50 years. However, sarcoidosis is an important cause of uveitis after 60 years of age. Sarcoidosis accounts for around 10% of all uveitides.<xref ref-type="bibr" rid="article-140077.r18">[18]</xref>&#x000a0;Late-onset&#x000a0;sarcoidosis&#x000a0;(diagnosis at a minimum age of 65 years) is more likely associated with uveitis, asthenia, and skin lesions.&#x000a0;Such patients may have a lower likelihood of erythema nodosum and asymptomatic chest X-ray abnormalities, and salivary glands biopsy may be particularly helpful in the diagnosis.<xref ref-type="bibr" rid="article-140077.r19">[19]</xref>&#x000a0;</p>
        <p>Children with age less than five years (early-onset sarcoidosis) have a&#x000a0;triad of skin disease (rashes), uveitis, and arthritis&#x000a0;and usually do not have&#x000a0;lung disease. Older children have a multisystemic involvement similar to adults with bilateral hilar lymphadenopathy and lung involvement.<xref ref-type="bibr" rid="article-140077.r20">[20]</xref></p>
      </sec>
      <sec id="article-140077.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Sarcoidosis is an inflammatory disease that, in sequence, involves the activation of antigen-driven CD4+ T lymphocytes, chemokine-induced migration of T cells to the disease site, local macrophage accumulation, and granuloma formation.<xref ref-type="bibr" rid="article-140077.r21">[21]</xref></p>
        <p>In cases with active sarcoidosis, there is dominant expression of interferon &#x003b3; (IFN &#x003b3;), interleukin (IL)-2, IL-12, and tumor necrosis alpha (TNF &#x003b1;) at the disease site. TNF&#x003b1; is the key granuloma-promoting cytokine.<xref ref-type="bibr" rid="article-140077.r21">[21]</xref>&#x000a0;The CD4:CD8 ratio is increased (more than 3.5) in the bronchoalveolar lavage fluid in sarcoidosis.<xref ref-type="bibr" rid="article-140077.r22">[22]</xref></p>
      </sec>
      <sec id="article-140077.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The formation of non-caseating (non-necrotizing) granuloma is the pathologic hallmark of sarcoidosis.<xref ref-type="bibr" rid="article-140077.r23">[23]</xref> Granulomas are characterized by a collection of mononuclear cells and macrophages, which differentiate into epithelioid cells and multinucleated giant cells and are surrounded by an accumulation of lymphocytes, fibroblasts, collagen, and plasma cells. Asteroid bodies are star-shaped structures within the cytoplasm. Schaumann bodies (conchoidal bodies) are basophilic laminated calcified nodules seen within the multinucleated giant cells.<xref ref-type="bibr" rid="article-140077.r24">[24]</xref>&#x000a0;Histological evidence of infection or foreign body is usually not seen.</p>
      </sec>
      <sec id="article-140077.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Sarcoidosis is a multisystem disease that predominantly involves lungs and thoracic lymph nodes. Patients may present with cough, dyspnea, and chest pain. Upper respiratory tract involvement leads to nonspecific rhinitis, recurrent sinusitis, and destructive lesions of the nasal septum and turbinates. Cutaneous manifestations include papules, nodules, plaques, ulcers, and erythema nodosum.<xref ref-type="bibr" rid="article-140077.r25">[25]</xref></p>
        <p>Cardiac involvement leads to the development of arrhythmias and heart blocks.<xref ref-type="bibr" rid="article-140077.r26">[26]</xref> Neurosarcoidosis occurs in about 5 to 10% of patients with sarcoidosis, with predominant involvement of basal leptomeninges and cranial nerves.<xref ref-type="bibr" rid="article-140077.r27">[27]</xref></p>
        <p>Ocular involvement in sarcoidosis is characterized by granulomatous inflammation of the eye and its adnexal tissues. Ocular involvement is the presenting feature in 30 to 40% of cases.<xref ref-type="bibr" rid="article-140077.r28">[28]</xref> The most common ocular features are uveitis (seen in 30 to 70%)&#x000a0;and conjunctival nodules (seen in 40%).<xref ref-type="bibr" rid="article-140077.r29">[29]</xref><xref ref-type="bibr" rid="article-140077.r1">[1]</xref></p>
        <p>
<bold>Orbital Disease</bold>
</p>
        <p>Involvement of orbital structures such as orbital fat, extraocular muscles, and optic nerve sheath leads to proptosis, globe displacement, pain, vision loss, and diplopia.<xref ref-type="bibr" rid="article-140077.r30">[30]</xref>&#x000a0;Most orbital lesions are located in the anterior orbit, especially the anteroinferior quadrant.<xref ref-type="bibr" rid="article-140077.r31">[31]</xref> Orbital mass secondary to sarcoidosis can cause compression of the central retinal artery leading to central retinal artery occlusion (CRAO).<xref ref-type="bibr" rid="article-140077.r32">[32]</xref></p>
        <p>
<bold>Lacrimal System Disease</bold>
</p>
        <p>Keratoconjunctivitis sicca (KCS) is a common manifestation of ocular sarcoidosis.<xref ref-type="bibr" rid="article-140077.r33">[33]</xref> Patients with keratoconjunctivitis sicca present with ocular irritation, epiphora, corneal infiltrate,&#x000a0;corneal infection,&#x000a0;and corneal scar. Inflammation of the lacrimal gland leads to enlargement of the gland with mass effects, proptosis, and dry eye syndrome (KCS) secondary to decreased aqueous production.<xref ref-type="bibr" rid="article-140077.r30">[30]</xref> Inflammation of nasolacrimal sac and lacrimal drainage system leads to obstruction of tear outflow with epiphora, pain, and pus pointing secondary to dacryocystitis.<xref ref-type="bibr" rid="article-140077.r34">[34]</xref></p>
        <p>
<bold>Eyelid and Ocular Surface Disease</bold>
</p>
        <p><bold>Eyelid -</bold> Erythematous eyelid swelling is seen in ocular sarcoidosis, which can vary in size from small papules to a large mass.<xref ref-type="bibr" rid="article-140077.r35">[35]</xref> Granulomatous inflammation of eyelids can lead to ptosis, entropion, trichiasis, and madarosis.<xref ref-type="bibr" rid="article-140077.r36">[36]</xref> Selective involvement of M&#x000fc;ller's muscle may lead to eyelid retraction.<xref ref-type="bibr" rid="article-140077.r37">[37]</xref></p>
        <p><bold>Conjunctiva - </bold>Conjunctival nodules are seen as white discrete conjunctival deposits predominantly affecting bulbar conjunctiva but can also be seen in the perilimbal area and palpebral conjunctiva.<xref ref-type="bibr" rid="article-140077.r38">[38]</xref> In some conditions, the conjunctival nodules mimic acute follicular conjunctivitis.<xref ref-type="bibr" rid="article-140077.r39">[39]</xref> Complications include the development of symblepharon secondary to chronic cicatricial inflammation.<xref ref-type="bibr" rid="article-140077.r40">[40]</xref></p>
        <p><bold>Sclera</bold> &#x02013; Scleritis is a rare manifestation of ocular sarcoidosis&#x000a0;and can manifest as diffuse anterior, nodular anterior, or posterior scleritis.<xref ref-type="bibr" rid="article-140077.r41">[41]</xref><xref ref-type="bibr" rid="article-140077.r42">[42]</xref></p>
        <p><bold>Cornea &#x02013;</bold> The most common corneal manifestation of ocular sarcoidosis is superficial punctate keratitis secondary to dry eye (keratoconjunctivitis sicca). Other manifestations include band-shaped keratopathy, peripheral ulcerative keratitis,&#x000a0;and interstitial keratitis.<xref ref-type="bibr" rid="article-140077.r43">[43]</xref><xref ref-type="bibr" rid="article-140077.r44">[44]</xref><xref ref-type="bibr" rid="article-140077.r45">[45]</xref></p>
        <p>
<bold>Uveitis</bold>
</p>
        <p>The mean age of presentation of uveitis is 42 years.&#x000a0;Most sarcoid uveitis is bilateral, and approximately 90% are chronic.<xref ref-type="bibr" rid="article-140077.r46">[46]</xref> Uveitis associated with sarcoidosis can be anterior, intermediate, posterior, or panuveitis.</p>
        <p><bold>Anterior uveitis</bold> &#x02013; The patient presents with eye pain, redness of eyes, blurred vision, and photophobia. Sarcoidosis is characterized by granulomatous uveitis, with mutton fat keratic precipitates [figure 1], iris, or trabecular meshwork nodules.&#x000a0;Busacca nodules are noted in the iris stroma, and the Koeppe nodules involve the pupillary margin. Berlin nodules are&#x000a0;present at the angle of the anterior chamber. Hypopyon is usually not seen in sarcoidosis.<xref ref-type="bibr" rid="article-140077.r47">[47]</xref></p>
        <p>Without appropriate treatment, there is a development of peripheral anterior synechiae with raised intraocular pressure or posterior synechiae with complicated cataracts. Patients with ocular sarcoid uveitis tend to develop raised intraocular pressure due to outflow obstruction due to trabecular meshwork block by inflammatory cells, trabecular meshwork nodules, or development of peripheral anterior synechiae.<xref ref-type="bibr" rid="article-140077.r48">[48]</xref></p>
        <p><bold>Intermediate uveitis</bold> &#x02013; Patients complain of either floaters or blurred vision. The most common cause of vision loss is the development of cystoid macular edema or vitreous inflammation. Inflammation of pars plana leads to the development of snowballs in the inferior vitreous and snow banking near ora serrata.<xref ref-type="bibr" rid="article-140077.r49">[49]</xref> Neovascularization may develop in the peripheral retina leading to vitreous hemorrhage in a few patients.<xref ref-type="bibr" rid="article-140077.r50">[50]</xref>&#x000a0;The vitreous may show the string of pearls appearance.</p>
        <p><bold>Posterior uveitis &#x02013;</bold> Choroidal inflammation leads to the development of choroidal granulomas, which may be unifocal or multifocal, and vary in size from small (like Dalen-Fuchs nodules) to significant (like choroidal tumors).<xref ref-type="bibr" rid="article-140077.r51">[51]</xref>&#x000a0;Inflammatory new vessels of the optic disc or the retina may cause vitreous hemorrhage.<xref ref-type="bibr" rid="article-140077.r52">[52]</xref></p>
        <p>Choroidal neovascularization may develop from choroidal granulomas, which affect vision when present in the posterior pole. Mid peripheral periphlebitis is characteristic of ocular sarcoidosis.&#x000a0;Occlusive vasculitis causing capillary nonperfusion and retinal new vessels may also occur. In severe cases, whitish-yellow perivascular exudates are seen along the retinal veins, classically described as "candle-wax drippings" or taches de bougie [Figure 2].<xref ref-type="bibr" rid="article-140077.r53">[53]</xref></p>
        <p>Posterior uveitis is complicated with the development of cystoid macular edema, epiretinal membrane formation, intraretinal hemorrhage, and vitreous hemorrhage.&#x000a0;</p>
        <p><bold>Neuro-ophthalmic Manifestations</bold>&#x000a0;</p>
        <p>&#x000a0;The optic nerve and facial nerve are the most commonly affected nerves in ocular sarcoidosis.<xref ref-type="bibr" rid="article-140077.r54">[54]</xref> Involvement of the optic nerve leads to the development of optic nerve granuloma [figure 3],&#x000a0;optic disc edema, and optic atrophy. Optic disc edema is secondary to either posterior uveitis, direct involvement of optic nerve, optic nerve sheath infiltration by granulomatous tissue, or secondary to raised intracranial pressure due to neurosarcoidosis.<xref ref-type="bibr" rid="article-140077.r55">[55]</xref><xref ref-type="bibr" rid="article-140077.r56">[56]</xref>&#x000a0;</p>
        <p>Some patients may complain of visual hallucinations,&#x000a0;nystagmus,&#x000a0;and pupillary abnormalities such as relative afferent pupillary defect or light near dissociation due to the involvement of optic pathways.<xref ref-type="bibr" rid="article-140077.r57">[57]</xref><xref ref-type="bibr" rid="article-140077.r58">[58]</xref>&#x000a0;</p>
        <p>Facial nerve involvement leads to lower motor neuron facial paresis leading to epiphora, exposure keratopathy, and corneal ulcers. Facial nerve involvement occurs due to inflammation in the parotid gland or secondary to meningitic reaction or direct compression of the facial nerve.<xref ref-type="bibr" rid="article-140077.r59">[59]</xref></p>
        <p><bold>Syndromic Associations</bold>&#x000a0;</p>
        <p><bold>L&#x000f6;fgren syndrome: </bold>It manifests as a triad of polyarthritis, erythema nodosum, and hilar lymphadenopathy. Other features include fever, malaise, uveitis, and parotitis.<xref ref-type="bibr" rid="article-140077.r60">[60]</xref></p>
        <p><bold>Heerfordt-Waldenstr&#x000f6;m syndrome (uveoparotid fever</bold>): It manifests as swelling of the parotid gland, fever, uveitis, and facial nerve palsy.<xref ref-type="bibr" rid="article-140077.r61">[61]</xref></p>
        <p><bold>Blau syndrome:</bold> It is an autosomal dominant disorder seen in children below the age of 4 years. Clinical features include arthritis, rash, and uveitis.<xref ref-type="bibr" rid="article-140077.r62">[62]</xref>&#x000a0;Other names of the disease (OMIM #186580) include familial juvenile systemic granulomatosis,&#x000a0;early-onset sarcoidosis, Jabs syndrome, granulomatous inflammatory arthritis, dermatitis, and uveitis. There is a mutation in the NOD2 (or CARD15) gene at chromosome&#x000a0;16q12.1.</p>
      </sec>
      <sec id="article-140077.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>For diagnosis of ocular sarcoidosis, three criteria must be met:</p>
        <list list-type="order">
          <list-item>
            <p>The patient must have clinical findings consistent with sarcoidosis as per the international workshop on ocular sarcoidosis (IWOS) criteria [Figure 4]</p>
          </list-item>
          <list-item>
            <p>Evidence of non-caseating granuloma on tissue biopsy</p>
          </list-item>
          <list-item>
            <p>Other causes of granulomatous inflammation (such as tuberculosis syphilis) should be ruled out.<xref ref-type="bibr" rid="article-140077.r63">[63]</xref></p>
          </list-item>
        </list>
        <p>The revised IWOS criteria for diagnosing ocular sarcoidosis [Figure 5] have removed the diagnosis of 'possible ocular sarcoidosis.'<xref ref-type="bibr" rid="article-140077.r22">[22]</xref></p>
        <p>The gold standard investigation in the diagnosis of sarcoidosis is tissue biopsy. In ocular sarcoidosis, tissue biopsy can be done on tissues including the eyelids, lacrimal glands, conjunctival nodules, and orbital tissues. However, at certain sites where tissue biopsy is not possible, imaging techniques such as chest x-ray, chest CT scan, serum angiotensin-converting enzyme (ACE) levels, serum calcium levels, and serum lysozyme levels may aid in the diagnosis of a probable or presumed ocular sarcoidosis.<xref ref-type="bibr" rid="article-140077.r63">[63]</xref>&#x000a0;</p>
        <p><bold>Fundus photography </bold>-&#x000a0; Helps document retinal findings and future objective comparisons of the lesions. Yellowish-white choroidal granulomas, periphlebitis, and other features of posterior uveitis can be documented as well as monitored on serial photographs.<xref ref-type="bibr" rid="article-140077.r64">[64]</xref></p>
        <p><bold>Fundus fluorescein angiography (FFA)</bold> &#x02013; FFA helps in documenting retinal vasculitis and detection of peripheral retinal neovascularization.<xref ref-type="bibr" rid="article-140077.r65">[65]</xref><xref ref-type="bibr" rid="article-140077.r66">[66]</xref>&#x000a0;FFA can reveal multiple retinal arterial macroaneurysms in an inflamed eye with or without optic disc granuloma, typical of ocular sarcoidosis.<xref ref-type="bibr" rid="article-140077.r67">[67]</xref></p>
        <p><bold>Fundus autofluorescence imaging (FAF) &#x02013;</bold> FAF helps detect sub-clinical retinal pigment epithelial changes in chorioretinal pathologies and monitors treatment response in uveitis patients with chorioretinal lesions.<xref ref-type="bibr" rid="article-140077.r68">[68]</xref></p>
        <p><bold>Optical coherence tomography (OCT)</bold> &#x02013; OCT helps assess and monitor macular edema and helps predict functional outcomes based on the structural integrity of various retinal layers.<xref ref-type="bibr" rid="article-140077.r69">[69]</xref> Enhanced depth OCT imaging can be useful in the detection of choroidal granulomas.<xref ref-type="bibr" rid="article-140077.r70">[70]</xref></p>
        <p><bold>Anterior segment OCT&#x000a0; &#x02013; </bold>Anterior segment OCT helps identify and document peripheral anterior synechiae and the extent of angle closure.<xref ref-type="bibr" rid="article-140077.r71">[71]</xref> In cases with granulomatous uveitis, it shows hyperreflective dots in the aqueous humor and on the posterior corneal surface.<xref ref-type="bibr" rid="article-140077.r72">[72]</xref></p>
        <p><bold>OCT of the optic nerve &#x02013; </bold>OCT of the optic nerve head helps investigate an optic nerve head granuloma.&#x000a0;It helps detect adjacent peripapillary retinal edema, monitor response to treatment, and evaluate the severity of optic nerve damage due to glaucoma.<xref ref-type="bibr" rid="article-140077.r73">[73]</xref><xref ref-type="bibr" rid="article-140077.r74">[74]</xref></p>
        <p><bold>Ultrasonography of the eye &#x02013; </bold>In patients with vitreous hemorrhage secondary to sarcoidosis, ultrasonography of the eye helps to understand the status of the retina. It helps as pre-operative aid in assessing the status of posterior vitreous detachment.</p>
        <p><bold>Ultrasound biomicroscopy (UBM) - &#x000a0;</bold>UBM helps objectively evaluate the inflammatory process in anterior chamber angle, iris, ciliary body, pars plana, and peripheral vitreous.<xref ref-type="bibr" rid="article-140077.r75">[75]</xref> It helps in the evaluation of ocular hypotony in cases of uveitis.<xref ref-type="bibr" rid="article-140077.r76">[76]</xref></p>
        <p><bold>Visual fields</bold> &#x02013; A wide range of visual field defects can be seen either due to glaucomatous optic neuropathy or ischemic optic neuropathy. Patients with ischemic optic neuropathy can present with central or centrocecal scotomas, hemianopic field defect, or altitudinal field defect.<xref ref-type="bibr" rid="article-140077.r77">[77]</xref></p>
        <p><bold>Diagnostic vitrectomy</bold> &#x02013; In limited cases, the vitreous sample obtained by vitrectomy can be used for diagnostic analysis. High mobility group box -1 (HMGB1), a pro-inflammatory cytokine, is detected in high levels in the vitreous of patients with ocular sarcoidosis.<xref ref-type="bibr" rid="article-140077.r78">[78]</xref></p>
        <p>
<bold>Systemic Investigations</bold>
</p>
        <p><bold>Chest X-ray &#x02013;</bold>&#x000a0;Bilateral hilar lymphadenopathy is the classical radiological feature of sarcoidosis.<xref ref-type="bibr" rid="article-140077.r79">[79]</xref> Lung parenchymal infiltrates appear in around 20 to 50% of the patients.<xref ref-type="bibr" rid="article-140077.r80">[80]</xref> Lung volume loss, hilar retraction, and linear opaque bands may be seen when lung fibrosis occurs.<xref ref-type="bibr" rid="article-140077.r81">[81]</xref></p>
        <p><bold>High resolution computed tomography (HRCT) chest</bold><bold>&#x000a0;&#x02013;</bold> HRCT scans are superior to conventional chest X-rays in delineating hilar lymphadenopathy, understanding lung parenchymal damage, and differentiating inflammation from fibrosis.<xref ref-type="bibr" rid="article-140077.r82">[82]</xref> Characteristic features of HRCT chest in sarcoidosis include mediastinal lymphadenopathy, lung parenchymal nodular opacities, nodular opacities&#x000a0;at the bronchovascular bundles, predominant involvement of mid or upper lung zones, and ground-glass opacities.<xref ref-type="bibr" rid="article-140077.r83">[83]</xref></p>
        <p><bold>Pulmonary function tests</bold> &#x02013; Pulmonary function tests typically reveal a restrictive pattern of ventilatory function. The tests show decreased lung volume and decreased carbon monoxide diffusing capacity.<xref ref-type="bibr" rid="article-140077.r84">[84]</xref></p>
        <p><bold>Serum angiotensin-converting enzyme (SACE)</bold>
<bold>assay</bold> &#x02013; SACE levels are elevated in about 30 to 80% of patients with sarcoidosis.<xref ref-type="bibr" rid="article-140077.r85">[85]</xref> However, about 20% of patients show false positive elevated levels of SACE.&#x000a0;SACE may also be normal in patients with active disease.</p>
        <p><bold>Bronchoalveolar lavage (BAL) &#x02013;</bold> BAL fluid analysis shows an increased number of activated T lymphocytes, alveolar macrophages, and inflammatory cytokines. In 85% of patients with pulmonary sarcoidosis, lymphocytosis is seen with normal or low granulocyte count.<xref ref-type="bibr" rid="article-140077.r86">[86]</xref> However, the BAL cell profile is not specific for sarcoidosis.<xref ref-type="bibr" rid="article-140077.r87">[87]</xref></p>
        <p><bold>Radionuclide techniques &#x02013;</bold> Radionuclide techniques include Gallium (Ga) scans fluoro-2deoxy-glucose (FDG) positron emission tomography (PET) scans. Uptake of Gallium helps identify appropriate sites to take the biopsy.<xref ref-type="bibr" rid="article-140077.r88">[88]</xref> The uptake of Gallium by intrathoracic lymph nodes resembles the Greek letter lambda (Lambda sign), and uptake in bilateral parotid and lacrimal gland resembles a panda face (Panda sign).<xref ref-type="bibr" rid="article-140077.r89">[89]</xref> PET scan helps identify lung activity in pulmonary disease and sarcoidosis activity at non-pulmonary sites such as bone, cardiac, and the nervous system.<xref ref-type="bibr" rid="article-140077.r90">[90]</xref><xref ref-type="bibr" rid="article-140077.r91">[91]</xref><xref ref-type="bibr" rid="article-140077.r92">[92]</xref><xref ref-type="bibr" rid="article-140077.r93">[93]</xref></p>
        <p><bold>Lung Biopsy &#x02013;</bold> Transbronchial lung biopsy (TBLB) using a flexible fiberoptic bronchoscopy (FFB) is the diagnostic procedure of choice in patients with pulmonary sarcoidosis with a sensitivity range of 60 to 90% depending on the stage of the disease.<xref ref-type="bibr" rid="article-140077.r94">[94]</xref> In the presence of lymphadenopathy, transbronchial needle aspiration (TBNA) biopsies are diagnostic in 63 to 90% of cases.<xref ref-type="bibr" rid="article-140077.r95">[95]</xref><xref ref-type="bibr" rid="article-140077.r96">[96]</xref> Biopsy shows the presence of non-caseating granulomas.</p>
        <p><bold>Kveim-Siltzbach test &#x02013;</bold>&#x000a0;This test involves intradermal injection of a suspension of granuloma containing spleen or lymph node from a patient with sarcoidosis.<xref ref-type="bibr" rid="article-140077.r97">[97]</xref> A positive test shows the development of papule at the injection site within 4-6 weeks, which on biopsy shows non-caseating granuloma.<xref ref-type="bibr" rid="article-140077.r98">[98]</xref> This test is now vaguely in use and is of historical interest.<xref ref-type="bibr" rid="article-140077.r99">[99]</xref></p>
        <p><bold>MRI (magnetic resonance imaging) of the brain &#x02013;</bold> MRI brain in neurosarcoidosis reveals a wide spectrum of findings such as periventricular and white matter lesions, leptomeningeal enhancement, solitary or multiple supra- and infratentorial brain lesions, and involvement of cranial nerves.<xref ref-type="bibr" rid="article-140077.r100">[100]</xref></p>
      </sec>
      <sec id="article-140077.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Corticosteroids</bold>
</p>
        <p>Corticosteroids are potent anti-inflammatory agents used in the management of uveitis.&#x000a0;They can be used topically as eye drops to treat anterior uveitis. However,&#x000a0;topical steroids are insufficient in the control of posterior uveitis. The most commonly used topical corticosteroids are prednisolone acetate 1% or difluprednate 0.05%.<xref ref-type="bibr" rid="article-140077.r101">[101]</xref></p>
        <p>
<bold>Regional corticosteroids </bold>
</p>
        <p>These agents are used in cases of posterior uveitis or when the patient is poorly compliant to frequent dosages of topical corticosteroids. They can be given as posterior subtenon injection in a dose of 20&#x000a0;to 40 mg of triamcinolone acetonide&#x000a0;or intravitreal injection of 1&#x000a0;to 4 mg of triamcinolone acetonide.<xref ref-type="bibr" rid="article-140077.r102">[102]</xref><xref ref-type="bibr" rid="article-140077.r103">[103]</xref><xref ref-type="bibr" rid="article-140077.r102">[102]</xref></p>
        <p>Long-acting sustained slow release steroid implants such as 0.7 mg of dexamethasone, 0.19 mg of fluocinolone acetonide, or 0.59 mg of fluocinolone acetonide&#x000a0;provide longer periods of anti-inflammatory effect. The regional corticosteroids may cause glaucoma and cataracts, and thus the patients should be observed closely and promptly treated for the complications.<xref ref-type="bibr" rid="article-140077.r104">[104]</xref><xref ref-type="bibr" rid="article-140077.r105">[105]</xref><xref ref-type="bibr" rid="article-140077.r104">[104]</xref></p>
        <p>
<bold>Systemic steroids </bold>
</p>
        <p>Systemically dosed steroids are used in cases of bilateral uveitis with systemic involvement or when there is poor disease control with local steroid use. Prednisolone in the dose of 1&#x000a0;to 1.5 mg/kg/day initially followed by slow tapering is the usual treatment protocol.</p>
        <p>
<bold>Cycloplegic Agents</bold>
</p>
        <p>These agents are used to relieve ciliary spasms and associated ocular pain. They help in breaking or preventing posterior synechiae. Commonly used agents include cyclopentolate 1%, homatropine 2%, and atropine 1%.</p>
        <p>
<bold>Systemic Immunosuppressive Agents</bold>
</p>
        <p>These agents are used in cases of corticosteroid-resistant cases or steroid-dependent cases where the side effects of the steroid regimen outweigh the anti-inflammatory effects. Most commonly used agents for the treatment of non-infectious uveitis are methotrexate&#x000a0;(7.5&#x000a0;to 25 mg /week; oral, subcutaneous, or intramuscular route), mycophenolate mofetil&#x000a0;(500&#x02013;1500 mg bd; oral route), cyclosporine&#x000a0;(2.5&#x000a0;to 10 mg/kg/day bd; oral route), and azathioprine&#x000a0;(1&#x000a0;to 4 mg/kg/day; oral route).<xref ref-type="bibr" rid="article-140077.r106">[106]</xref><xref ref-type="bibr" rid="article-140077.r107">[107]</xref><xref ref-type="bibr" rid="article-140077.r108">[108]</xref></p>
        <p>
<bold>Biologic Agents</bold>
</p>
        <p>These are used in cases of refractory non-infectious uveitis. The most commonly used biologic agents are tumor necrosis factor-alpha inhibitors (TNF &#x003b1;) such as infliximab, adalimumab, etanercept, and golimumab. These agents promise to offer a new option in resistant cases. The patient should be tested for latent tuberculosis and hepatitis B before starting biologic agents to prevent the reactivation of infection.<xref ref-type="bibr" rid="article-140077.r109">[109]</xref>&#x000a0;Interestingly, a 'sarcoid-like granulomatosis' has been reported following anti-TNF&#x000a0;therapy, including etanercept, infliximab, and adalimumab for various indications, including rheumatoid arthritis and spondyloarthritis.<xref ref-type="bibr" rid="article-140077.r110">[110]</xref></p>
        <p>
<bold>Treatment of Orbital Disease</bold>
</p>
        <p>Orbital inflammation is typically amenable to systemic steroids or immunosuppressive agents.&#x000a0;In cases with chronic eyelid or lacrimal gland swelling, a biopsy is&#x000a0;necessary to differentiate it from tumors.</p>
        <p>
<bold>Treatment of Ocular Surface Disease</bold>
</p>
        <p>Conjunctival lesions and KCS usually responds to topical cyclosporine eye drops.<xref ref-type="bibr" rid="article-140077.r111">[111]</xref> For scleritis, initial treatment is with systemic non-steroidal anti-inflammatory drugs (NSAIDs), with steroids and immunosuppressants reserved for resistant cases.</p>
        <p>
<bold>Treatment of Ocular Complications</bold>
</p>
        <p>Glaucoma is one of the most common uveitis complications and a serious side effect of chronic corticosteroid use. Glaucoma needs to be monitored at each visit and requires early intervention either medically or surgically. Cataract surgery is usually planned after three months of disease inactivity. Uveitic cystoid macular edema is one of the common causes of ocular morbidity and requires intervention in the form of anti-inflammatory agents.</p>
        <p>In certain cases, posterior subtenon triamcinolone, intravitreal injection of steroids (triamcinolone, dexamethasone implant, or fluocinolone implant), or anti-VEGF (vascular endothelial growth factor) agents like bevacizumab&#x000a0;or ranibizumab&#x000a0;are required to control cystoid macular edema. Development of epiretinal membrane at the macula, vitreomacular traction, and vitreous hemorrhage may warrant surgical intervention in the form of vitrectomy.<xref ref-type="bibr" rid="article-140077.r112">[112]</xref><xref ref-type="bibr" rid="article-140077.r113">[113]</xref></p>
      </sec>
      <sec id="article-140077.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Sarcoidosis is a disease that can simultaneously involve various parts of the eye with multiple presentations.&#x000a0;Differential diagnoses should be considered for various ocular findings, including iris nodules, intermediate uveitis, chorioretinitis,&#x000a0;retinitis,&#x000a0;choroidal infiltrates, dacryoadenopathy, and peripheral retinal neovascularization.<xref ref-type="bibr" rid="article-140077.r114">[114]</xref> The most common differential diagnoses to be considered include:</p>
        <p><bold>Iris nodules</bold>: Iris nodules may also be seen in inflammatory conditions such as tuberculosis, leprosy, and syphilis, tumors of the iris, and infiltration by retinoblastoma.</p>
        <p><bold>Intermediate uveitis</bold>: Intermediate uveitis may also be idiopathic or seen in Lyme disease, tuberculosis, and multiple sclerosis.</p>
        <p><bold>Chorioretinitis</bold>: Chorioretinitis may also be seen in tuberculosis, histoplasmosis, toxoplasmosis, and syphilis.</p>
        <p><bold>Choroidal infiltrates</bold>: &#x000a0;Choroidal infiltrates may also be&#x000a0;present in white dot syndromes such as acute posterior multifocal placoid pigment epitheliopathy, birdshot choroidopathy; Vogt-Koyanagi-Harada disease, amelanotic melanoma, and metastatic infiltrates.</p>
        <p><bold>Dacryoadenopathy:</bold> Dacryoadenopathy may also be seen in tuberculosis, brucellosis, Hodgkin's lymphoma, and parotid gland tumors.</p>
        <p><bold>Peripheral retinal neovascularization:</bold> Peripheral retinal neovascularization may also be&#x000a0;present in diabetic retinopathy,&#x000a0;vein occlusions, sickle cell retinopathy, and Eales disease.<xref ref-type="bibr" rid="article-140077.r115">[115]</xref><xref ref-type="bibr" rid="article-140077.r116">[116]</xref></p>
      </sec>
      <sec id="article-140077.s11" sec-type="Staging">
        <title>Staging</title>
        <p>On chest X-ray posteroanterior (PA) view, the pulmonary disease&#x000a0;is divided into five stages:</p>
        <list list-type="bullet">
          <list-item>
            <p>Stage 0: Unremarkable chest X-ray</p>
          </list-item>
          <list-item>
            <p>Stage I: Enlargement of the hilar or mediastinal lymph nodes</p>
          </list-item>
          <list-item>
            <p>Stage II: Parenchymal disease along with&#x000a0;enlargement of the lymph nodes</p>
          </list-item>
          <list-item>
            <p>Stage III: Only parenchymal disease</p>
          </list-item>
          <list-item>
            <p>Stage IV: Pulmonary fibrosis or end-stage lung disease<xref ref-type="bibr" rid="article-140077.r117">[117]</xref><xref ref-type="bibr" rid="article-140077.r118">[118]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140077.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Outcomes in&#x000a0;cases of ocular sarcoidosis depend on several variables such as the severity of disease, chronicity of disease, time of presentation to healthcare facilities, and secondary complications due to long-standing ocular inflammation.<xref ref-type="bibr" rid="article-140077.r46">[46]</xref> The overall prognosis for ocular sarcoidosis is usually good, and most patients recover without significant functional damage.<xref ref-type="bibr" rid="article-140077.r119">[119]</xref></p>
        <p>Irreversible loss of vision usually occurs due to glaucoma and chronic maculopathy.&#x000a0;In a prospective study by Edelsten et al., it was noted that the prognosis of sarcoid uveitis is not affected by extraocular disease.&#x000a0;The presence of the HLA DQB1*0201 allele is proven to be protective against severe sarcoidosis.<xref ref-type="bibr" rid="article-140077.r120">[120]</xref>&#x000a0;</p>
        <p>Prognostic factors for poor visual outcomes include black race, delayed presentation to a subspecialist, glaucoma, intermediate or posterior uveitis, cystoid macular edema, and use of systemic steroids.&#x000a0;The overall mortality from sarcoidosis may reach 5% or even 10% with neurosarcoidosis. Poor prognostic factors in sarcoidosis include female gender (compared to male), early-onset disease, African-American ethnicity, chronic sarcoidosis, Annexin A11 gene, HLA-DQB1*1501, HLA-DQB1*0602, pulmonary fibrosis, poor pulmonary function test, optic nerve involvement, panuveitis, lupus pernio, chronic arthritis, and stage 3 or 4 of the disease in radiography.<xref ref-type="bibr" rid="article-140077.r121">[121]</xref></p>
      </sec>
      <sec id="article-140077.s13" sec-type="Complications">
        <title>Complications</title>
        <p>
<bold>Ocular Complications</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Glaucoma</p>
          </list-item>
          <list-item>
            <p>Cataract</p>
          </list-item>
          <list-item>
            <p>Central retinal artery occlusion</p>
          </list-item>
          <list-item>
            <p>Cystoid macular edema</p>
          </list-item>
          <list-item>
            <p>Epiretinal membrane</p>
          </list-item>
          <list-item>
            <p>Intraretinal hemorrhage</p>
          </list-item>
          <list-item>
            <p>Vitreous hemorrhage</p>
          </list-item>
          <list-item>
            <p>Phthisis<xref ref-type="bibr" rid="article-140077.r122">[122]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Systemic Complications</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Neurosarcoidosis</p>
          </list-item>
          <list-item>
            <p>Pulmonary hypertension</p>
          </list-item>
          <list-item>
            <p>End-stage lung damage</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140077.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Although ocular sarcoidosis can have an acute presentation with a limited course, some patients develop a chronic unrelenting form of the disease.<xref ref-type="bibr" rid="article-140077.r123">[123]</xref> Patients with chronic disease should be made aware of complications due to chronic inflammation such as glaucoma, cataract, cystoid macular edema, and epiretinal membrane formation. Patients should also be made aware of the need for medical compliance and drug-related adverse effects. Patients with sarcoid uveitis are known to carry a risk of neurological involvement for at least the next 15 years.<xref ref-type="bibr" rid="article-140077.r124">[124]</xref></p>
      </sec>
      <sec id="article-140077.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Sarcoidosis is a multisystem disease and requires effective coordination between an ophthalmologist, pulmonologist, infectious disease specialist, dermatologist, rheumatologist, radiologist, cardiologist, neurologist, and pharmacist. At each visit, an ophthalmic assistant should measure intraocular pressure in addition to vision, as both the disease and its treatment, i.e., steroids, can lead to raised intraocular pressure. The pharmacist plays a vital role in monitoring compliance to treatment and educating patients about the side effects of various drugs used in the treatment.&#x000a0;Clinical overlap between sarcoidosis and tuberculosis is not uncommon, and&#x000a0;an infectious disease specialist should be consulted in such cases. Nursing staff plays an important role in ensuring compliance with therapy. An optimal interprofessional collaboration can ensure the best outcomes in patients with ocular sarcoidosis.</p>
      </sec>
      <sec id="article-140077.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140077&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140077">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/ocular-sarcoidosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=140077">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/140077/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=140077">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-140077.s17">
        <fig id="article-140077.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Figure1: slit lamp photograph showing mutton-fat keratic precipitates Contributed by Koushik Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="granulomatous__uveitis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140077.s18">
        <fig id="article-140077.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Figure 2: Fundus photography of left eye show mid peripheral vasculitis with yellowish-white perivascular exudates (candle wax dripping) Contributed by Kalpana B Murthy, MRCOphth</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="perivasculitis__x1x" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140077.s19">
        <fig id="article-140077.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Figure 3: Fundus photograph showing optic nerve head swelling and granuloma Contributed by Kalpana B Murthy, MRCOphth</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="optic__nerve__head__granuloma__x1x" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140077.s20">
        <fig id="article-140077.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Figure 4: International workshop on ocular sarcoidosis (2009) diagnostic criteria Contributed by Simakurthy Sriram, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IWOS" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140077.s21">
        <fig id="article-140077.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis [PMID: 30798264] Contributed by Koushik Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="revised__criteria__for__diagnosis__of__ocular__sarcoidosis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-140077.s22">
        <title>References</title>
        <ref id="article-140077.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasadhika</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rosenbaum</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Ocular Sarcoidosis.</article-title>
            <source>Clin Chest Med</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>669</fpage>
            <page-range>669-83</page-range>
            <pub-id pub-id-type="pmid">26593141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ikonomopoulos</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Gorgoulis</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Kastrinakis</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Galanos</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Karameris</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kittas</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Experimental inoculation of laboratory animals with samples collected from sarcoidal patients and molecular diagnostic evaluation of the results.</article-title>
            <source>In Vivo</source>
            <year>2000</year>
            <season>Nov-Dec</season>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>761</fpage>
            <page-range>761-5</page-range>
            <pub-id pub-id-type="pmid">11204496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heyll</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meckenstock</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Aul</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>S&#x000f6;hngen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Borchard</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hadding</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>M&#x000f6;dder</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Leschke</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Possible transmission of sarcoidosis via allogeneic bone marrow transplantation.</article-title>
            <source>Bone Marrow Transplant</source>
            <year>1994</year>
            <month>Jul</month>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>161</fpage>
            <page-range>161-4</page-range>
            <pub-id pub-id-type="pmid">7951107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agrawal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kee</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Ang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tun Hang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kon</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zierhut</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pavesio</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis or sarcoidosis: Opposite ends of the same disease spectrum?</article-title>
            <source>Tuberculosis (Edinb)</source>
            <year>2016</year>
            <month>May</month>
            <volume>98</volume>
            <fpage>21</fpage>
            <page-range>21-6</page-range>
            <pub-id pub-id-type="pmid">27156614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eishi</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Etiologic link between sarcoidosis and Propionibacterium acnes.</article-title>
            <source>Respir Investig</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>56</fpage>
            <page-range>56-68</page-range>
            <pub-id pub-id-type="pmid">23790733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Newman</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Occupational causes of sarcoidosis.</article-title>
            <source>Curr Opin Allergy Clin Immunol</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>145</fpage>
            <page-range>145-50</page-range>
            <pub-id pub-id-type="pmid">22314258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kucera</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Rybicki</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Kirkey</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Coon</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Major</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Maliarik</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Iannuzzi</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Occupational risk factors for sarcoidosis in African-American siblings.</article-title>
            <source>Chest</source>
            <year>2003</year>
            <month>May</month>
            <volume>123</volume>
            <issue>5</issue>
            <fpage>1527</fpage>
            <page-range>1527-35</page-range>
            <pub-id pub-id-type="pmid">12740270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kreider</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Christie</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barnard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bresnitz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Judson</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lackland</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Rossman</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Relationship of environmental exposures to the clinical phenotype of sarcoidosis.</article-title>
            <source>Chest</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>128</volume>
            <issue>1</issue>
            <fpage>207</fpage>
            <page-range>207-15</page-range>
            <pub-id pub-id-type="pmid">16002937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barnard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Canner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martyny</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McCammon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bresnitz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rossman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rybicki</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Weinberger</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Moller</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>McLennan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hunninghake</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>DePalo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Baughman</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Iannuzzi</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Judson</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Knatterud</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Teirstein</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Yeager</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Johns</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Rabin</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Cherniack</surname>
                <given-names>R</given-names>
              </name>
              <collab>ACCESS Research Group</collab>
            </person-group>
            <article-title>Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS).</article-title>
            <source>J Occup Environ Med</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>47</volume>
            <issue>3</issue>
            <fpage>226</fpage>
            <page-range>226-34</page-range>
            <pub-id pub-id-type="pmid">15761318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rossman</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Frederick</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maliarik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iannuzzi</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Rybicki</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Magira</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Beznik-Cizman</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Monos</surname>
                <given-names>D</given-names>
              </name>
              <collab>ACCESS Group</collab>
            </person-group>
            <article-title>HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.</article-title>
            <source>Am J Hum Genet</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>73</volume>
            <issue>4</issue>
            <fpage>720</fpage>
            <page-range>720-35</page-range>
            <pub-id pub-id-type="pmid">14508706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehra</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Bovornkitti</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>HLA and sarcoidosis.</article-title>
            <source>Sarcoidosis</source>
            <year>1988</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>87</fpage>
            <page-range>87-9</page-range>
            <pub-id pub-id-type="pmid">3227192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Calender</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weichhart</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Valeyre</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pacheco</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Current Insights in Genetics of Sarcoidosis: Functional and Clinical Impacts.</article-title>
            <source>J Clin Med</source>
            <year>2020</year>
            <month>Aug</month>
            <day>13</day>
            <volume>9</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">32823753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iannuzzi</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Genetics of sarcoidosis.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-21</page-range>
            <pub-id pub-id-type="pmid">17330189</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rybicki</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Major</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Popovich</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Maliarik</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Iannuzzi</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.</article-title>
            <source>Am J Epidemiol</source>
            <year>1997</year>
            <month>Feb</month>
            <day>01</day>
            <volume>145</volume>
            <issue>3</issue>
            <fpage>234</fpage>
            <page-range>234-41</page-range>
            <pub-id pub-id-type="pmid">9012596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baughman</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Field</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Costabel</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Crystal</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Culver</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Drent</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Judson</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wolff</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Sarcoidosis in America. Analysis Based on Health Care Use.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>13</volume>
            <issue>8</issue>
            <fpage>1244</fpage>
            <page-range>1244-52</page-range>
            <pub-id pub-id-type="pmid">27509154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iannuzzi</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Rybicki</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Teirstein</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Sarcoidosis.</article-title>
            <source>N Engl J Med</source>
            <year>2007</year>
            <month>Nov</month>
            <day>22</day>
            <volume>357</volume>
            <issue>21</issue>
            <fpage>2153</fpage>
            <page-range>2153-65</page-range>
            <pub-id pub-id-type="pmid">18032765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rothova</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alberts</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Glasius</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kijlstra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Buitenhuis</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Breebaart</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for ocular sarcoidosis.</article-title>
            <source>Doc Ophthalmol</source>
            <year>1989</year>
            <month>Aug</month>
            <volume>72</volume>
            <issue>3-4</issue>
            <fpage>287</fpage>
            <page-range>287-96</page-range>
            <pub-id pub-id-type="pmid">2625091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yemm</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Pecen</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Fliney</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Palestine</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Chest X-ray and Uveitis Evaluation in a Population with Low Incidence of Sarcoidosis.</article-title>
            <source>Ophthalmol Ther</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>577</fpage>
            <page-range>577-584</page-range>
            <pub-id pub-id-type="pmid">32613593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varron</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cottin</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Schott</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Broussolle</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>S&#x000e8;ve</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Late-onset sarcoidosis: a comparative study.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2012</year>
            <month>May</month>
            <volume>91</volume>
            <issue>3</issue>
            <fpage>137</fpage>
            <page-range>137-143</page-range>
            <pub-id pub-id-type="pmid">22543629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shetty</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Gedalia</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Childhood sarcoidosis: A rare but fascinating disorder.</article-title>
            <source>Pediatr Rheumatol Online J</source>
            <year>2008</year>
            <month>Sep</month>
            <day>23</day>
            <volume>6</volume>
            <fpage>16</fpage>
            <pub-id pub-id-type="pmid">18811966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patterson</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>The Pathogenesis of Pulmonary Sarcoidosis and Implications for Treatment.</article-title>
            <source>Chest</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>153</volume>
            <issue>6</issue>
            <fpage>1432</fpage>
            <page-range>1432-1442</page-range>
            <pub-id pub-id-type="pmid">29224832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mochizuki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Takase</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kaburaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Acharya</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>NA</given-names>
              </name>
              <collab>International Workshop on Ocular Sarcoidosis Study Group</collab>
            </person-group>
            <article-title>Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>103</volume>
            <issue>10</issue>
            <fpage>1418</fpage>
            <page-range>1418-1422</page-range>
            <pub-id pub-id-type="pmid">30798264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Polverino</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Balestro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Spagnolo</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Clinical Presentations, Pathogenesis, and Therapy of Sarcoidosis: State of the Art.</article-title>
            <source>J Clin Med</source>
            <year>2020</year>
            <month>Jul</month>
            <day>24</day>
            <volume>9</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">32722050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rajwanshi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Schaumann body in a case of sarcoidosis diagnosed on transbronchial FNAC.</article-title>
            <source>J Cytol</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>88</fpage>
            <page-range>88-9</page-range>
            <pub-id pub-id-type="pmid">21713156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ma&#x000f1;&#x000e1;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Marcoval</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Skin manifestations of sarcoidosis.</article-title>
            <source>Presse Med</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>41</volume>
            <issue>6 Pt 2</issue>
            <fpage>e355</fpage>
            <page-range>e355-74</page-range>
            <pub-id pub-id-type="pmid">22579238</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lynch</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bradfield</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fishbein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shivkumar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tung</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>372</fpage>
            <page-range>372-90</page-range>
            <pub-id pub-id-type="pmid">25007089</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapelon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ziza</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Piette</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Raguin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wechsler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bitker</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Bl&#x000e9;try</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Laplane</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bousser</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Neurosarcoidosis: signs, course and treatment in 35 confirmed cases.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1990</year>
            <month>Sep</month>
            <volume>69</volume>
            <issue>5</issue>
            <fpage>261</fpage>
            <page-range>261-76</page-range>
            <pub-id pub-id-type="pmid">2205782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ungprasert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tooley</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Crowson</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Matteson</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Clinical Characteristics of Ocular Sarcoidosis: A Population-Based Study 1976-2013.</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>2019</year>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>389</fpage>
            <page-range>389-395</page-range>
            <pub-id pub-id-type="pmid">29023165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rothova</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Ocular involvement in sarcoidosis.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2000</year>
            <month>Jan</month>
            <volume>84</volume>
            <issue>1</issue>
            <fpage>110</fpage>
            <page-range>110-6</page-range>
            <pub-id pub-id-type="pmid">10611110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mavrikakis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rootman</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Diverse clinical presentations of orbital sarcoid.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>144</volume>
            <issue>5</issue>
            <fpage>769</fpage>
            <page-range>769-775</page-range>
            <pub-id pub-id-type="pmid">17869205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prabhakaran</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Saeed</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Esmaeli</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>McNab</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Valenzuela</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Leibovitch</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kesler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sivak-Callcott</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hoyama</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Selva</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Orbital and adnexal sarcoidosis.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>125</volume>
            <issue>12</issue>
            <fpage>1657</fpage>
            <page-range>1657-62</page-range>
            <pub-id pub-id-type="pmid">18071118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Korgavkar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zahid</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De Lott</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Prabhakar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Foerster</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Besirli</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Vision Loss After Central Retinal Artery Occlusion Secondary to Orbital Sarcoid Mass.</article-title>
            <source>Ophthalmic Plast Reconstr Surg</source>
            <year>2016</year>
            <season>Mar-Apr</season>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>e37</fpage>
            <page-range>e37-40</page-range>
            <pub-id pub-id-type="pmid">25072221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>JONES</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>STEVENSON</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Keratoconjunctivitis sicca due to sarcoidosis.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1957</year>
            <month>Mar</month>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>153</fpage>
            <page-range>153-60</page-range>
            <pub-id pub-id-type="pmid">13404198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kay</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Saffra</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Har-El</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Isolated sarcoidosis of the lacrimal sac without systemic manifestations.</article-title>
            <source>Am J Otolaryngol</source>
            <year>2002</year>
            <season>Jan-Feb</season>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-5</page-range>
            <pub-id pub-id-type="pmid">11791250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hall</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Sarcoidosis of the eyelid skin.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>119</volume>
            <issue>1</issue>
            <fpage>100</fpage>
            <page-range>100-1</page-range>
            <pub-id pub-id-type="pmid">7825675</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kersten</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Bernardini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kulwin</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Destructive eyelid lesions in sarcoidosis.</article-title>
            <source>Ophthalmic Plast Reconstr Surg</source>
            <year>2001</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-5</page-range>
            <pub-id pub-id-type="pmid">11281585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Behbehani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nipper</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Bilyk</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Systemic sarcoidosis manifested as unilateral eyelid retraction.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>124</volume>
            <issue>4</issue>
            <fpage>599</fpage>
            <page-range>599-600</page-range>
            <pub-id pub-id-type="pmid">16606895</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dithmar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Waring</surname>
                <given-names>GO</given-names>
              </name>
              <name>
                <surname>Goldblum</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Grossniklaus</surname>
                <given-names>HE</given-names>
              </name>
            </person-group>
            <article-title>Conjunctival deposits as an initial manifestation of sarcoidosis.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>128</volume>
            <issue>3</issue>
            <fpage>361</fpage>
            <page-range>361-2</page-range>
            <pub-id pub-id-type="pmid">10511034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manrique Lipa</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>de los Bueis</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>De los R&#x000ed;os</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Manrique Lipa</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Sarcoidosis presenting as acute bulbar follicular conjunctivitis.</article-title>
            <source>Clin Exp Optom</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>93</volume>
            <issue>5</issue>
            <fpage>363</fpage>
            <page-range>363-5</page-range>
            <pub-id pub-id-type="pmid">20718787</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geggel</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Mensher</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Cicatricial conjunctivitis in sarcoidosis: recognition and treatment.</article-title>
            <source>Ann Ophthalmol</source>
            <year>1989</year>
            <month>Mar</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>92</fpage>
            <page-range>92-4</page-range>
            <pub-id pub-id-type="pmid">2735697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heiligenhaus</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Michel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Nodular scleritis in a patient with sarcoidosis.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2003</year>
            <month>Apr</month>
            <volume>87</volume>
            <issue>4</issue>
            <fpage>507</fpage>
            <page-range>507-8</page-range>
            <pub-id pub-id-type="pmid">12642326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dodds</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Lowder</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Barnhorst</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Lavertu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Caravella</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Posterior scleritis with annular ciliochoroidal detachment.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1995</year>
            <month>Nov</month>
            <volume>120</volume>
            <issue>5</issue>
            <fpage>677</fpage>
            <page-range>677-9</page-range>
            <pub-id pub-id-type="pmid">7485375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crick</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Hoyle</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Smellie</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>THE EYES IN SARCOIDOSIS.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1961</year>
            <month>Jul</month>
            <volume>45</volume>
            <issue>7</issue>
            <fpage>461</fpage>
            <page-range>461-81</page-range>
            <pub-id pub-id-type="pmid">18170695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siracuse-Lee</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Saffra</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Peripheral ulcerative keratitis in sarcoidosis: a case report.</article-title>
            <source>Cornea</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>5</issue>
            <fpage>618</fpage>
            <page-range>618-20</page-range>
            <pub-id pub-id-type="pmid">16783154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lennarson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Barney</surname>
                <given-names>NP</given-names>
              </name>
            </person-group>
            <article-title>Interstitial keratitis as presenting ophthalmic sign of sarcoidosis in a child.</article-title>
            <source>J Pediatr Ophthalmol Strabismus</source>
            <year>1995</year>
            <season>May-Jun</season>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>194</fpage>
            <page-range>194-6</page-range>
            <pub-id pub-id-type="pmid">7636703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dana</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Merayo-Lloves</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schaumberg</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Prognosticators for visual outcome in sarcoid uveitis.</article-title>
            <source>Ophthalmology</source>
            <year>1996</year>
            <month>Nov</month>
            <volume>103</volume>
            <issue>11</issue>
            <fpage>1846</fpage>
            <page-range>1846-53</page-range>
            <pub-id pub-id-type="pmid">8942880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zaidi</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Ying</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Daniel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gangaputra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rosenbaum</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Suhler</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Thorne</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Jabs</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Levy-Clarke</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Nussenblatt</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Kempen</surname>
                <given-names>JH</given-names>
              </name>
              <collab>Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study</collab>
            </person-group>
            <article-title>Hypopyon in patients with uveitis.</article-title>
            <source>Ophthalmology</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>117</volume>
            <issue>2</issue>
            <fpage>366</fpage>
            <page-range>366-72</page-range>
            <pub-id pub-id-type="pmid">20006905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shimizu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maruyama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yokoyama</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tsuda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakazawa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of uveitic glaucoma and evaluation of its surgical treatment.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2014</year>
            <volume>8</volume>
            <fpage>2383</fpage>
            <page-range>2383-9</page-range>
            <pub-id pub-id-type="pmid">25473265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r49">
          <label>49</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Chauhan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Pars Planitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">28613790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spalton</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Sanders</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Fundus changes in histologically confirmed sarcoidosis.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1981</year>
            <month>May</month>
            <volume>65</volume>
            <issue>5</issue>
            <fpage>348</fpage>
            <page-range>348-58</page-range>
            <pub-id pub-id-type="pmid">6166318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Letocha</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Retinal changes in sarcoidosis.</article-title>
            <source>Can J Ophthalmol</source>
            <year>1975</year>
            <month>Apr</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>184</fpage>
            <page-range>184-92</page-range>
            <pub-id pub-id-type="pmid">1125843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumawat</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Inflammatory optic disc neovascularisation managed with oral steroids/immunosuppressants and intravitreal ranibizumab.</article-title>
            <source>BMJ Case Rep</source>
            <year>2017</year>
            <month>Nov</month>
            <day>03</day>
            <volume>2017</volume>
            <pub-id pub-id-type="pmid">29102974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>GOULD</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>KAUFMAN</surname>
                <given-names>HE</given-names>
              </name>
            </person-group>
            <article-title>Sarcoid of the fundus.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1961</year>
            <month>Mar</month>
            <volume>65</volume>
            <fpage>453</fpage>
            <page-range>453-6</page-range>
            <pub-id pub-id-type="pmid">13707501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Eggenberger</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Neuro-ophthalmic sarcoidosis.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>423</fpage>
            <page-range>423-9</page-range>
            <pub-id pub-id-type="pmid">20736834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gass</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Olson</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Sarcoidosis with optic nerve and retinal involvement.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1976</year>
            <month>Jun</month>
            <volume>94</volume>
            <issue>6</issue>
            <fpage>945</fpage>
            <page-range>945-50</page-range>
            <pub-id pub-id-type="pmid">938285</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r56">
          <label>56</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Pirau</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lui</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <chapter-title>Neurosarcoidosis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>3</day>
            <pub-id pub-id-type="pmid">30521189</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poole</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Argyll Robertson pupils due to neurosarcoidosis: evidence for site of lesion.</article-title>
            <source>Br Med J (Clin Res Ed)</source>
            <year>1984</year>
            <month>Aug</month>
            <day>11</day>
            <volume>289</volume>
            <issue>6441</issue>
            <fpage>356</fpage>
            <pub-id pub-id-type="pmid">6432097</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r58">
          <label>58</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Simakurthy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Marcus Gunn Pupil</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">32491607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zajicek</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Scolding</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Rovaris</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Evanson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moseley</surname>
                <given-names>IF</given-names>
              </name>
              <name>
                <surname>Scadding</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Chamoun</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>WI</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Central nervous system sarcoidosis--diagnosis and management.</article-title>
            <source>QJM</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>92</volume>
            <issue>2</issue>
            <fpage>103</fpage>
            <page-range>103-17</page-range>
            <pub-id pub-id-type="pmid">10209662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chauhan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jandial</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sandal</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Acute arthritis, skin rash and Lofgren's syndrome.</article-title>
            <source>BMJ Case Rep</source>
            <year>2021</year>
            <month>Jun</month>
            <day>07</day>
            <volume>14</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">34099443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Denny</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Fotino</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>The Heerfordt-Waldenstr&#x000f6;m syndrome as an initial presentation of sarcoidosis.</article-title>
            <source>Proc (Bayl Univ Med Cent)</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>390</fpage>
            <page-range>390-2</page-range>
            <pub-id pub-id-type="pmid">24082416</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sfriso</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Caso</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tognon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Galozzi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gava</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Punzi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Blau syndrome, clinical and genetic aspects.</article-title>
            <source>Autoimmun Rev</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>44</fpage>
            <page-range>44-51</page-range>
            <pub-id pub-id-type="pmid">22884558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herbort</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Mochizuki</surname>
                <given-names>M</given-names>
              </name>
              <collab>members of Scientific Committee of First International Workshop on Ocular Sarcoidosis</collab>
            </person-group>
            <article-title>International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS).</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>2009</year>
            <season>May-Jun</season>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>160</fpage>
            <page-range>160-9</page-range>
            <pub-id pub-id-type="pmid">19585358</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dickson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sadiq</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>High</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>QD</given-names>
              </name>
              <name>
                <surname>Sepah</surname>
                <given-names>YJ</given-names>
              </name>
            </person-group>
            <article-title>Assessment of vitreous haze using ultra-wide field retinal imaging.</article-title>
            <source>J Ophthalmic Inflamm Infect</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <pub-id pub-id-type="pmid">27687961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nicholson</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Nigam</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Agr&#x000f3;n</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dalal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jacobs-El</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>da Rocha Lima</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cunningham</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nussenblatt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sen</surname>
                <given-names>HN</given-names>
              </name>
            </person-group>
            <article-title>Comparison of wide-field fluorescein angiography and 9-field montage angiography in uveitis.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>157</volume>
            <issue>3</issue>
            <fpage>673</fpage>
            <page-range>673-7</page-range>
            <pub-id pub-id-type="pmid">24321475</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r66">
          <label>66</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ruia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Fluorescein Angiography</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35015403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r67">
          <label>67</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Singh</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Retinal Macroaneurysm</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">35015432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reznicek</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Seidensticker</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Stumpf</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kampik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thurau</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kernt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Neubauer</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Systematic analysis of wide-field fundus autofluorescence (FAF) imaging in posterior uveitis.</article-title>
            <source>Curr Eye Res</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>164</fpage>
            <page-range>164-71</page-range>
            <pub-id pub-id-type="pmid">24144279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pakzad-Vaezi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Or</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Forooghian</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Optical coherence tomography in the diagnosis and management of uveitis.</article-title>
            <source>Can J Ophthalmol</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>49</volume>
            <issue>1</issue>
            <fpage>18</fpage>
            <page-range>18-29</page-range>
            <pub-id pub-id-type="pmid">24513352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Invernizzi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mapelli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Viola</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cigada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cimino</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ratiglia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Staurenghi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Choroidal granulomas visualized by enhanced depth imaging optical coherence tomography.</article-title>
            <source>Retina</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>525</fpage>
            <page-range>525-31</page-range>
            <pub-id pub-id-type="pmid">25105317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Su</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>See</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Chew</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Nolan</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Aung</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Degree of angle closure and extent of peripheral anterior synechiae: an anterior segment OCT study.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>92</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-7</page-range>
            <pub-id pub-id-type="pmid">17584995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Concilio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cennamo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Giordano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fossataro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>D'Andrea</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ciampa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Naddei</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Orlando</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tranfa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Alessio</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Anterior Segment-Optical Coherence Tomography features in Blau syndrome.</article-title>
            <source>Photodiagnosis Photodyn Ther</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>34</volume>
            <fpage>102278</fpage>
            <pub-id pub-id-type="pmid">33813016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hickman</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Quhill</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pepper</surname>
                <given-names>IM</given-names>
              </name>
            </person-group>
            <article-title>The Evolution of an Optic Nerve Head Granuloma Due to Sarcoidosis.</article-title>
            <source>Neuroophthalmology</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>59</fpage>
            <page-range>59-68</page-range>
            <pub-id pub-id-type="pmid">27928387</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sathyan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shilpa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Anitha</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Optical Coherence Tomography in Glaucoma.</article-title>
            <source>J Curr Glaucoma Pract</source>
            <year>2012</year>
            <season>Jan-Apr</season>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-5</page-range>
            <pub-id pub-id-type="pmid">27990063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tran</surname>
                <given-names>VT</given-names>
              </name>
              <name>
                <surname>LeHoang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Herbort</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Value of high-frequency ultrasound biomicroscopy in uveitis.</article-title>
            <source>Eye (Lond)</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>15</volume>
            <issue>Pt 1</issue>
            <fpage>23</fpage>
            <page-range>23-30</page-range>
            <pub-id pub-id-type="pmid">11318288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roters</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Szurman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Engels</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Bartz-Schmidt</surname>
                <given-names>KU</given-names>
              </name>
              <name>
                <surname>Krieglstein</surname>
                <given-names>GK</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound biomicroscopy in chronic ocular hypotony: its impact on diagnosis and management.</article-title>
            <source>Retina</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>581</fpage>
            <page-range>581-8</page-range>
            <pub-id pub-id-type="pmid">12441723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kidd</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Plant</surname>
                <given-names>GT</given-names>
              </name>
            </person-group>
            <article-title>Optic neuropathy associated with systemic sarcoidosis.</article-title>
            <source>Neurol Neuroimmunol Neuroinflamm</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>3</volume>
            <issue>5</issue>
            <fpage>e270</fpage>
            <pub-id pub-id-type="pmid">27536707</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takeuchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taguchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Karasawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sakurai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Harimoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Association of High-Mobility Group Box-1 With Th Cell-Related Cytokines in the Vitreous of Ocular Sarcoidosis Patients.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2017</year>
            <month>Jan</month>
            <day>01</day>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>528</fpage>
            <page-range>528-537</page-range>
            <pub-id pub-id-type="pmid">28125840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lynch</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Kazerooni</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Gay</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary sarcoidosis.</article-title>
            <source>Clin Chest Med</source>
            <year>1997</year>
            <month>Dec</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>755</fpage>
            <page-range>755-85</page-range>
            <pub-id pub-id-type="pmid">9413657</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hillerdal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>N&#x000f6;u</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Osterman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schmekel</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Sarcoidosis: epidemiology and prognosis. A 15-year European study.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1984</year>
            <month>Jul</month>
            <volume>130</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-32</page-range>
            <pub-id pub-id-type="pmid">6742607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lynch</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Koss</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary sarcoidosis.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-74</page-range>
            <pub-id pub-id-type="pmid">17330192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lynch</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Computed tomographic scanning in sarcoidosis.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>393</fpage>
            <page-range>393-418</page-range>
            <pub-id pub-id-type="pmid">16088560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hennebicque</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Nunes</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Brillet</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Moulahi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Valeyre</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Brauner</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>CT findings in severe thoracic sarcoidosis.</article-title>
            <source>Eur Radiol</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-30</page-range>
            <pub-id pub-id-type="pmid">15449010</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soto-Gomez</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Nambiar</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Management of Sarcoidosis.</article-title>
            <source>Am Fam Physician</source>
            <year>2016</year>
            <month>May</month>
            <day>15</day>
            <volume>93</volume>
            <issue>10</issue>
            <fpage>840</fpage>
            <page-range>840-8</page-range>
            <pub-id pub-id-type="pmid">27175719</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lieberman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schleissner</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Nosal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sastre</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mishkin</surname>
                <given-names>FS</given-names>
              </name>
            </person-group>
            <article-title>Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis. A longitudinal study of serum ACE, 67gallium scans, chest roentgenograms, and pulmonary function.</article-title>
            <source>Chest</source>
            <year>1983</year>
            <month>Nov</month>
            <volume>84</volume>
            <issue>5</issue>
            <fpage>522</fpage>
            <page-range>522-8</page-range>
            <pub-id pub-id-type="pmid">6313303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Welker</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>J&#x000f6;rres</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Costabel</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Magnussen</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases.</article-title>
            <source>Eur Respir J</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>1000</fpage>
            <page-range>1000-6</page-range>
            <pub-id pub-id-type="pmid">15572545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drent</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mulder</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Wagenaar</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Hoogsteden</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>van Velzen-Blad</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>van den Bosch</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Differences in BAL fluid variables in interstitial lung diseases evaluated by discriminant analysis.</article-title>
            <source>Eur Respir J</source>
            <year>1993</year>
            <month>Jun</month>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>803</fpage>
            <page-range>803-10</page-range>
            <pub-id pub-id-type="pmid">8339798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ismail</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Embong</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Hitam</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Gallium scan in diagnosing ocular sarcoidosis.</article-title>
            <source>Malays J Med Sci</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <page-range>64-7</page-range>
            <pub-id pub-id-type="pmid">22605949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yoshimizu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Suga</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Orihashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Soejima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kaneko</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kawamura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakanishi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Utsumi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>[The appearance of "lambda" and "panda" sign on Ga-67 scintigraphy in sarcoidosis].</article-title>
            <source>Kaku Igaku</source>
            <year>1991</year>
            <month>Oct</month>
            <volume>28</volume>
            <issue>10</issue>
            <fpage>1151</fpage>
            <page-range>1151-7</page-range>
            <pub-id pub-id-type="pmid">1800775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brudin</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Valind</surname>
                <given-names>SO</given-names>
              </name>
              <name>
                <surname>Rhodes</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Pantin</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Sweatman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography.</article-title>
            <source>Eur J Nucl Med</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>297</fpage>
            <page-range>297-305</page-range>
            <pub-id pub-id-type="pmid">8005153</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ponzo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Raphael</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Amorosi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>FDG positron emission tomography of bone involvement in sarcoidosis.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>182</volume>
            <issue>4</issue>
            <fpage>975</fpage>
            <page-range>975-7</page-range>
            <pub-id pub-id-type="pmid">15039174</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takeda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yokoyama</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hiroi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sakata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Harada</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Murakawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nagai</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis.</article-title>
            <source>Circulation</source>
            <year>2002</year>
            <month>Mar</month>
            <day>05</day>
            <volume>105</volume>
            <issue>9</issue>
            <fpage>1144</fpage>
            <page-range>1144-5</page-range>
            <pub-id pub-id-type="pmid">11877369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dubey</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Miletich</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Wasay</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mechtler</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Bakshi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis.</article-title>
            <source>J Neurol Sci</source>
            <year>2002</year>
            <month>Dec</month>
            <day>15</day>
            <volume>205</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-81</page-range>
            <pub-id pub-id-type="pmid">12409188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gilman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>KP</given-names>
              </name>
            </person-group>
            <article-title>Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1980</year>
            <month>Nov</month>
            <volume>122</volume>
            <issue>5</issue>
            <fpage>721</fpage>
            <page-range>721-4</page-range>
            <pub-id pub-id-type="pmid">7447156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trisolini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lazzari Agli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cancellieri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Poletti</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Candoli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Paioli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Alifano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tinelli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Patelli</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Transbronchial needle aspiration improves the diagnostic yield of bronchoscopy in sarcoidosis.</article-title>
            <source>Sarcoidosis Vasc Diffuse Lung Dis</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>147</fpage>
            <page-range>147-51</page-range>
            <pub-id pub-id-type="pmid">15281436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trisolini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lazzari Agli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cancellieri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Poletti</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tinelli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Baruzzi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Patelli</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The value of flexible transbronchial needle aspiration in the diagnosis of stage I sarcoidosis.</article-title>
            <source>Chest</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>124</volume>
            <issue>6</issue>
            <fpage>2126</fpage>
            <page-range>2126-30</page-range>
            <pub-id pub-id-type="pmid">14665490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>James</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Kveim-Siltzbach test revisited.</article-title>
            <source>Sarcoidosis</source>
            <year>1991</year>
            <month>Mar</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <page-range>6-9</page-range>
            <pub-id pub-id-type="pmid">1669943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mikhail</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>DN</given-names>
              </name>
            </person-group>
            <article-title>The Kveim test in sarcoidosis.</article-title>
            <source>Postgrad Med J</source>
            <year>1970</year>
            <month>Aug</month>
            <volume>46</volume>
            <issue>538</issue>
            <fpage>484</fpage>
            <page-range>484-5</page-range>
            <pub-id pub-id-type="pmid">5481096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Newman</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Maier</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Sarcoidosis.</article-title>
            <source>N Engl J Med</source>
            <year>1997</year>
            <month>Apr</month>
            <day>24</day>
            <volume>336</volume>
            <issue>17</issue>
            <fpage>1224</fpage>
            <page-range>1224-34</page-range>
            <pub-id pub-id-type="pmid">9110911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fels</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Riegel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Javaheripour-Otto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Obenauer</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Neurosarcoidosis: findings in MRI.</article-title>
            <source>Clin Imaging</source>
            <year>2004</year>
            <season>May-Jun</season>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>166</fpage>
            <page-range>166-9</page-range>
            <pub-id pub-id-type="pmid">15158219</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sheppard</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Toyos</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Kempen</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2014</year>
            <month>May</month>
            <day>06</day>
            <volume>55</volume>
            <issue>5</issue>
            <fpage>2993</fpage>
            <page-range>2993-3002</page-range>
            <pub-id pub-id-type="pmid">24677110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kok</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Maycock</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>McCluskey</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lightman</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Outcome of intravitreal triamcinolone in uveitis.</article-title>
            <source>Ophthalmology</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>112</volume>
            <issue>11</issue>
            <fpage>1916.e1</fpage>
            <page-range>1916.e1-7</page-range>
            <pub-id pub-id-type="pmid">16171868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khurana</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Porco</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.</article-title>
            <source>Retina</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>35</volume>
            <issue>8</issue>
            <fpage>1640</fpage>
            <page-range>1640-6</page-range>
            <pub-id pub-id-type="pmid">25741813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jaffe</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Callanan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Comstock</surname>
                <given-names>T</given-names>
              </name>
              <collab>Fluocinolone Acetonide Uveitis Study Group</collab>
            </person-group>
            <article-title>Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.</article-title>
            <source>Ophthalmology</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>113</volume>
            <issue>6</issue>
            <fpage>1020</fpage>
            <page-range>1020-7</page-range>
            <pub-id pub-id-type="pmid">16690128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pavesio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zierhut</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bairi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Comstock</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Usner</surname>
                <given-names>DW</given-names>
              </name>
              <collab>Fluocinolone Acetonide Study Group</collab>
            </person-group>
            <article-title>Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis.</article-title>
            <source>Ophthalmology</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>117</volume>
            <issue>3</issue>
            <fpage>567</fpage>
            <page-range>567-75, 575.e1</page-range>
            <pub-id pub-id-type="pmid">20079922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gangaputra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Newcomb</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Liesegang</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Ka&#x000e7;maz</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Jabs</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Levy-Clarke</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Nussenblatt</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Rosenbaum</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Suhler</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Thorne</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kempen</surname>
                <given-names>JH</given-names>
              </name>
              <collab>Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study</collab>
            </person-group>
            <article-title>Methotrexate for ocular inflammatory diseases.</article-title>
            <source>Ophthalmology</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>116</volume>
            <issue>11</issue>
            <fpage>2188</fpage>
            <page-range>2188-98.e1</page-range>
            <pub-id pub-id-type="pmid">19748676</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ka&#x000e7;maz</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Kempen</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Newcomb</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Daniel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gangaputra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nussenblatt</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Rosenbaum</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Suhler</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Thorne</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Jabs</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Levy-Clarke</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Cyclosporine for ocular inflammatory diseases.</article-title>
            <source>Ophthalmology</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>117</volume>
            <issue>3</issue>
            <fpage>576</fpage>
            <page-range>576-84</page-range>
            <pub-id pub-id-type="pmid">20031223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasadhika</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kempen</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Newcomb</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Liesegang</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Pujari</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Rosenbaum</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Thorne</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Jabs</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Levy-Clarke</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Nussenblatt</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Suhler</surname>
                <given-names>EB</given-names>
              </name>
            </person-group>
            <article-title>Azathioprine for ocular inflammatory diseases.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>148</volume>
            <issue>4</issue>
            <fpage>500</fpage>
            <page-range>500-509.e2</page-range>
            <pub-id pub-id-type="pmid">19570522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r109">
          <label>109</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kane</surname>
                <given-names>SV</given-names>
              </name>
            </person-group>
            <article-title>Preparing for biologic or immunosuppressant therapy.</article-title>
            <source>Gastroenterol Hepatol (N Y)</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>7</volume>
            <issue>8</issue>
            <fpage>544</fpage>
            <page-range>544-6</page-range>
            <pub-id pub-id-type="pmid">22298992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Da&#x000ef;en</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Monnier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Claudepierre</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Constantin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eschard</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Houvenagel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Samimi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pavy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pertuiset</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Toussirot</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Combe</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Morel</surname>
                <given-names>J</given-names>
              </name>
              <collab>Club Rhumatismes et Inflammation (CRI)</collab>
            </person-group>
            <article-title>Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases.</article-title>
            <source>Rheumatology (Oxford)</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>48</volume>
            <issue>8</issue>
            <fpage>883</fpage>
            <page-range>883-6</page-range>
            <pub-id pub-id-type="pmid">19423648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r111">
          <label>111</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akpek</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Ilhan-Sarac</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>Topical cyclosporin in the treatment of chronic sarcoidosis of the conjunctiva.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>121</volume>
            <issue>9</issue>
            <fpage>1333</fpage>
            <page-range>1333-5</page-range>
            <pub-id pub-id-type="pmid">12963621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r112">
          <label>112</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cordero Coma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sobrin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Onal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Christen</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Intravitreal bevacizumab for treatment of uveitic macular edema.</article-title>
            <source>Ophthalmology</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>114</volume>
            <issue>8</issue>
            <fpage>1574</fpage>
            <page-range>1574-1579.e1</page-range>
            <pub-id pub-id-type="pmid">17363060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r113">
          <label>113</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Acharya</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Ranibizumab for refractory uveitis-related macular edema.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>148</volume>
            <issue>2</issue>
            <fpage>303</fpage>
            <page-range>303-309.e2</page-range>
            <pub-id pub-id-type="pmid">19427988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r114">
          <label>114</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Geetha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Chorioretinitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">31869169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r115">
          <label>115</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Shukla</surname>
                <given-names>UV</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Diabetic Retinopathy</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">32809640</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r116">
          <label>116</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Raizada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Eales Disease</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">32644547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r117">
          <label>117</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hamzeh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Maier</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Is it time to scrap Scadding and adopt computed tomography for initial evaluation of sarcoidosis?</article-title>
            <source>F1000Res</source>
            <year>2018</year>
            <volume>7</volume>
            <pub-id pub-id-type="pmid">29946423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r118">
          <label>118</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Rosado-de-Christenson</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>McAdams</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Fishback</surname>
                <given-names>NF</given-names>
              </name>
            </person-group>
            <article-title>Thoracic sarcoidosis: radiologic-pathologic correlation.</article-title>
            <source>Radiographics</source>
            <year>1995</year>
            <month>Mar</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>421</fpage>
            <page-range>421-37</page-range>
            <pub-id pub-id-type="pmid">7761646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r119">
          <label>119</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Huhti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Poukkula</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Course and outcome of ocular sarcoidosis.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1988</year>
            <month>Oct</month>
            <day>15</day>
            <volume>106</volume>
            <issue>4</issue>
            <fpage>467</fpage>
            <page-range>467-72</page-range>
            <pub-id pub-id-type="pmid">3177566</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r120">
          <label>120</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sato</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Grutters</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Pantelidis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mizzon</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Van Houte</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Lammers</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Van Den Bosch</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Welsh</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>Du Bois</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis.</article-title>
            <source>Am J Respir Cell Mol Biol</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>406</fpage>
            <page-range>406-12</page-range>
            <pub-id pub-id-type="pmid">12356573</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r121">
          <label>121</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kobak</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Catch the rainbow: Prognostic factor of sarcoidosis.</article-title>
            <source>Lung India</source>
            <year>2020</year>
            <season>Sep-Oct</season>
            <volume>37</volume>
            <issue>5</issue>
            <fpage>425</fpage>
            <page-range>425-432</page-range>
            <pub-id pub-id-type="pmid">32883904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r122">
          <label>122</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Temkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sagar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kashyap</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pushker</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>YR</given-names>
              </name>
            </person-group>
            <article-title>Phthisis Bulbi-a Clinicopathological Perspective.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2018</year>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>788</fpage>
            <page-range>788-803</page-range>
            <pub-id pub-id-type="pmid">29902388</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r123">
          <label>123</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matsou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tsaousis</surname>
                <given-names>KT</given-names>
              </name>
            </person-group>
            <article-title>Management of chronic ocular sarcoidosis: challenges and solutions.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2018</year>
            <volume>12</volume>
            <fpage>519</fpage>
            <page-range>519-532</page-range>
            <pub-id pub-id-type="pmid">29593377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140077.r124">
          <label>124</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Edelsten</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Joynes</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Stanford</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>The ocular and systemic prognosis of patients presenting with sarcoid uveitis.</article-title>
            <source>Eye (Lond)</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>13 ( Pt 6)</volume>
            <fpage>748</fpage>
            <page-range>748-53</page-range>
            <pub-id pub-id-type="pmid">10707138</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
